VIRUCID 200MG TABLETS

Χώρα: Κύπρος

Γλώσσα: Ελληνικά

Πηγή: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

Δραστική ουσία:

ACICLOVIR

Διαθέσιμο από:

DELORBIS PHARMACEUTICALS LTD (0000009620) 17 ATHINON STREET, ERGATES INDUSTRIAL AREA, LEFKOSIA, 2081, 28629

Φαρμακολογική κατηγορία (ATC):

J05AB01

INN (Διεθνής Όνομα):

ACICLOVIR

Δοσολογία:

200MG

Φαρμακοτεχνική μορφή:

TABLETS

Σύνθεση:

ACICLOVIR (0059277893) 200MG

Οδός χορήγησης:

ORAL USE

Τρόπος διάθεσης:

Εθνική Διαδικασία

Θεραπευτική περιοχή:

ACICLOVIR

Περίληψη προϊόντος:

Νομικό καθεστώς: Με Ιατρική Συνταγή; PACK WITH 30 TABS IN BLISTER(S) (950003601) 30 TABLET - Εγκεκριμένο - Με Ιατρική Συνταγή

Φύλλο οδηγιών χρήσης

COMPARATIVE TABLE – ENGLISH PIL VS GREEK PIL
PACKAGE LEAFLET: INFORMATION FOR THE USER
VIRUCID 200 MG TABLETS
VIRUCID 400 MG TABLETS
Aciclovir
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE
IT CONTAINS IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It
might harm them, even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1. What Virucid is and what it is used for
2. What you need to know before you take Virucid
3. How to take Virucid
4. Possible side effects
5. How to store Virucid
6. Contents of the pack and other information
1. WHAT VIRUCID IS AND WHAT IT IS USED FOR
Virucid contains a medicine called aciclovir. This belongs to a group
of medicines
ΦΎΛΛΟ ΟΔΗΓΙΏΝ ΧΡΉΣΗΣ: ΠΛΗΡΟΦΟΡΊΕΣ ΓΙΑ
ΤΟΝ ΧΡΉΣΤΗ
VIRUCID 200 MG ΔΙΣΚΊΑ
VIRUCID 400 MG ΔΙΣΚΊΑ
Ακυκλοβίρη
ΔΙΑΒΆΣΤΕ ΠΡΟΣΕΚΤΙΚΆ ΟΛΌΚΛΗΡΟ ΤΟ ΦΎΛΛΟ
ΟΔΗΓΙΏΝ ΧΡΉΣΗΣ ΠΡΟΤΟΎ
ΑΡΧΊΣΕΤΕ ΝΑ ΠΑΊΡΝΕΤΕ ΑΥΤΌ ΤΟ ΦΆΡΜΑΚΟ,
ΔΙΌΤΙ ΠΕΡΙΛΑΜΒΆΝΕΙ ΣΗΜΑΝΤΙΚΈΣ
ΠΛΗΡΟΦΟΡΊΕΣ ΓΙΑ ΣΑΣ.

Φυλάξτε αυτό το φύλλο οδηγιών χρήσης.
Ίσως χρειαστεί να το
διαβάσετε ξανά.

Εάν έχετε περαιτέρω απορίες, ρωτήστε
το γιατρό ή το φαρμακοποιό
σας.

Η συνταγή για αυτό το φάρμακο
χορηγήθηκε αποκλειστικά για σας. Δεν
πρέπει να δώσετε το φάρμακο σε άλλους.
Μπορεί να τους προκαλέσει
βλάβη, ακόμα και όταν τ

Αρχείο Π.Χ.Π.

SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICAL PRODUCT
Virucid 200 mg Tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 200 mg aciclovir.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablets.
Virucid 200 mg tablets are white, concave, round tablets, scored on
one side.
4.
CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Virucid Tablets are indicated for the treatment of herpes simplex
virus infections of the skin and mucous
membranes including initial and recurrent genital herpes (excluding
neonatal HSV and severe HSV
infections in immunocompromised children).
Virucid Tablets are indicated for the suppression (prevention of
recurrences) of recurrent herpes simplex
infections in immunocompetent patients.
Virucid Tablets are indicated for the prophylaxis of herpes simplex
infections in immuno-compromised
patients.
Virucid Tablets are indicated for the treatment of varicella
(chickenpox) and herpes zoster (shingles)
infections.
Route of administration: Oral
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
1
Ensure that patients on high doses of aciclovir are adequately
hydrated.
Dosage in adults
Treatment of herpes simplex infections: 200 mg Virucid should be taken
five times daily at approximately
four hourly intervals omitting the night time dose. Treatment should
continue for 5 days, but in severe
initial infections this may have to be extended.
In severely immunocompromised patients (e.g. after marrow transplant)
or in patients with impaired
absorption from the gut the dose can be doubled to 400 mg Virucid or
alternatively intravenous dosing
could be considered.
Dosing should begin as early as possible after the start of an
infection; for recurrent episodes this should
preferably be during the prodromal period or when lesions first
appear.
Suppression of herpes simplex infections in immunocompetent patients:
200 mg Virucid should be taken
four times daily at approximately six-hourly intervals.
Many patients may be conveniently managed on a regimen of 400 mg